Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Antiviral Research
|
January 13, 2009
Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?
Kathie-Anne Walters, Michael G Katze
Future Medicinal Chemistry
|
November 20, 2014
Systems biology: unlocking the complexities of disease to enhance medicine
Yuqing He, Kathie-Anne Walters, Inyoul Lee, et al.
Scientific Reports
|
May 16, 2019
A biological function based biomarker panel optimization process
Min Young Lee, Taek-Kyun Kim, Kathie-Anne Walters, et al.
Nature Medicine
|
February 18, 2022
More autopsy studies are needed to understand the pathogenesis of severe COVID-19
Scott P Layne, Kathie-Anne Walters, John C Kash, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibiotics
A Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens
A Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Nature Reviews. Immunology
|
July 26, 2008
Innate immune modulation by RNA viruses: emerging insights from functional genomics
Michael G Katze, Jamie L Fornek, Robert E Palermo, et al.
Journal of Virology
|
July 16, 2004
Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen
Kathie-Anne Walters, Michael A Joyce, William R Addison, et al.
BMC Genomics
|
October 30, 2015
Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist
Kathie-Anne Walters, Rachael Olsufka, Rolf E Kuestner, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening
Kathie-Anne Walters, Graham A Tipples, Marchelle I Allen, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Antiviral Research
|
January 13, 2009
Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?
Kathie-Anne Walters, Michael G Katze
Future Medicinal Chemistry
|
November 20, 2014
Systems biology: unlocking the complexities of disease to enhance medicine
Yuqing He, Kathie-Anne Walters, Inyoul Lee, et al.
Scientific Reports
|
May 16, 2019
A biological function based biomarker panel optimization process
Min Young Lee, Taek-Kyun Kim, Kathie-Anne Walters, et al.
Nature Medicine
|
February 18, 2022
More autopsy studies are needed to understand the pathogenesis of severe COVID-19
Scott P Layne, Kathie-Anne Walters, John C Kash, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibiotics
A Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens
A Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Nature Reviews. Immunology
|
July 26, 2008
Innate immune modulation by RNA viruses: emerging insights from functional genomics
Michael G Katze, Jamie L Fornek, Robert E Palermo, et al.
Journal of Virology
|
July 16, 2004
Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen
Kathie-Anne Walters, Michael A Joyce, William R Addison, et al.
BMC Genomics
|
October 30, 2015
Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist
Kathie-Anne Walters, Rachael Olsufka, Rolf E Kuestner, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening
Kathie-Anne Walters, Graham A Tipples, Marchelle I Allen, et al.
Page
of 4